Emergent BioSolutions (EBS) Receives FDA Approval for BioThrax Treatment
Go back to Emergent BioSolutions (EBS) Receives FDA Approval for BioThrax Treatment| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 5.70 +0.06 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.64 | 52 Week High | $44.38 | |||
| Open | $5.56 | 52 Week Low | $24.47 | |||
| Day High | $5.75 | P/E | 285.00 | |||
| Day Low | $5.55 | EPS | $0.02 | |||
| Volume | 192,586 | |||||
